AGIOS PHARM reports a Return on Equity (ROE) of -38.10%.

What is AGIO's dividend yield?

AGIOS PHARM offers a dividend yield of 0.00%.

What is AGIO's Deepscope Quality Score?

Deepscope rates AGIO's overall financial quality at 0 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy AGIO?

Deepscope's AI Timing Score for AGIO is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does AGIO belong to?

AGIOS PHARM is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu AGIO (NASDAQ) | AGIOS PHARM

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-09 | FS: 2026-03-31)

AGIO

AGIOS PHARM

US:NASDAQ STOCK Healthcare >> Biotechnology News 96

USD 28.14

0.70 (2.55%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-38.1%

ROE

-35.7%

ROA

0.00%

Div Yield

AGIOS PHARM
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 28.14 Price 0.70 (2.55%) Day Change	NEWS SCORE: 96

AGIO Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 0) và Thời điểm mua ...(Sign In to See)...

Loading chart...

0 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

41%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	28.14
PBV / Sector	1.47 / 4.71 GOOD
Earning Per Share	-7.29

PE / Sector	N/A / 17.58
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	22.02 M GREAT
Average 1W Daily Value	20.43 M GREAT

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

54%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-639.84 / 468.85
NPM Average (%) / Sector	-499.68 / -1,531.69
NPM Change Average (%) / Sector	-104.41 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-35.66 / 31.69
ROA Average (%) / Sector	-16.65 / -353.18
ROA Change Average (%) / Sector	-68.38 / 5,214.65
ROE (%) / Sector	-38.10 / 10.58
ROE Average (%) / Sector	-18.69 / 27.64
ROE Change Average (%) / Sector	-65.89 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 3.68

Chi tiết đăng ký

Analyze Date	2026-06-10 09:43:43
Symbol	AGIO
Name	AGIOS PHARM
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	59.47 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,631.90 / 8,889.42

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 88 Sidney Street, Cambridge, MA, United States, 02139

Phone: 617 649 8600

Website: https://www.agios.com

Employees: 539

Sector: Healthcare >> Biotechnology

Description: Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.